Table 2 Patients characteristics for the training set and validation set

Gender (M/F)

23/27

14/16

Age

61.8 ± 14.1

61.1 ± 15.2

 [min, max]

[21, 90]

[26, 91]

 Congestive heart failure

3

3

 Chronic kidney failure

1

0

 Cardiogenic shock

1

0

 Dilated cardiomyopathy

3

1

 Ischemic heart disease

10

4

 Pulmonary edema

0

1

 Pulmonary embolism

1

0

 Sepsis

0

1

 Stroke

2

4

 Takotsubo

1

0

 Others

28

16

LVEF (%)

43 ± 18

49 ± 13

LVEDV (ml)

114 ± 51

95 ± 37

MAPSE_med (mm)

10.8 ± 4.9

10.7 ± 3.9

MAPSE_lat (mm)

12.7 ± 4.3

13.1 ± 4.6

Mean MAPSE (mm)

11.7 ± 4.4

11.9 ± 4.1

LWFS (%)

12.0 ± 4.5

12.9 ± 3.6

CAMMFS (%)

12.5 ± 4.8

12.8 ± 3.9

LVLS (%)

-13.4 ± 5.8

-14.5 ± 4.7